Skip to content
Products

Modern cardiology products for the next era.

HeartSciences products help advance cardiology practices with more efficient and effective ECG workflows.

Software platform

MyoVista Insights

A device-agnostic, cloud-native ECG management system. Centralizes ECGs from major manufacturers, runs FDA-cleared and partner AI-ECG models, and pipes results into Epic.

  • Vendor-neutral 12-lead ECG ingestion
  • An AI marketplace with multiple algorithms available for each ECG
  • A searchable and filterable patient-centric worklist
  • Electronic Tools for ECG review
  • Epic TOOLBOX 2026 + HL7 FHIR integrations
Explore MyoVista Insights
Hardware device

MyoVista wavECG

A 12-lead resting ECG built to host AI-ECG algorithms on-device. Combines conventional ECG diagnostics with proprietary continuous wavelet transform signal processing for AI analysis at the point of care.

MyoVista wavECG device, three-quarter view
  • Conventional 12-lead ECG with on-device AI
  • Modern user interface
  • Compact, portable, clinical-grade form factor
  • Direct cloud sync to MyoVista Insights
Explore MyoVista wavECG
AI portfolio

AI-ECG Algorithms

A growing portfolio of FDA-clearance-pathway AI-ECG models targeting low and preserved ejection fraction, impaired cardiac relaxation, valvular disease, pulmonary embolism, right-ventricular function, and more. Each is validated through peer-reviewed research and surfaced through MyoVista Insights.

Pre-FDA

Low Ejection Fraction

Pre-FDA

Impaired Cardiac Relaxation

Development

Aortic Stenosis

Development

Pulmonary Embolism

  • Validated against echocardiography or cardiac MRI ground truth
  • Multi-center training and independent validation
  • Surfaced inside the Insights worklist with confidence scores
See the clinical evidence
Talk to us

Ready to walk through the platform?

See MyoVista Insights against your existing ECG workflow with our team.